Steps toward a globally available malaria vaccine Harnessing the potential of algae for future low cost vaccines

• Published in: Bioengineered Vol. 4; no. 3; pp. 164 - 167
• Main Authors: Jones, Carla S., Mayfield, Stephen P.
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.05.2013; Landes Bioscience
• Subjects: Addendum; algae; Antigens, Protozoan - genetics; Antigens, Protozoan - metabolism; Binding; Biology; Bioscience; Calcium; Cancer; Cell; Chlamydomonas reinhardtii; Chlamydomonas reinhardtii - genetics; Chlamydomonas reinhardtii - metabolism; chloroplast engineering; Cycle; Gene Expression; Humans; Landes; malaria; Malaria - parasitology; Malaria - prevention & control; Malaria Vaccines - genetics; Malaria Vaccines - metabolism; Organogenesis; Pfs48/45; Plasmodium falciparum; Plasmodium falciparum - genetics; Plasmodium falciparum - immunology; Plasmodium falciparum - physiology; protein expression; Proteins; transmission blocking vaccine; Plasmodium falciparum; Pfs48/45; Chlamydomonas reinhardtii; chloroplast engineering; algae; malaria; transmission blocking vaccine; protein expression

Malaria is an infectious disease that threatens half of the world's population. This debilitating disease is caused by infection from parasites of the genus Plasmodium. Insecticides, bed nets and drug therapies have lowered the prevalence and death rate associated with malaria but this disease...